Drugs / Ginkgo Biloba Extract 761
last change Dec 2017 re-read 3 minutes ago

Ginkgo Biloba Extract 761

Developed for
cognitive impairment with or without cerebellar ataxia

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 4 NCT02982603 Comparator May 2015 → Dec 2017 cognitive impairment with or without cerebellar ataxia, drug allergy Dongzhimen Hospital, Beijing Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ginkgo Biloba Extract 761 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02982603 ↗